Regulation of the sympathetic nervous system by nitric oxide and oxidative stress in the rostral ventrolateral medulla: 2012 Academic Conference Award from the Japanese Society of Hypertension

Hypertension Research

Volumn 36, Issue 10, 2013, Pages 845-851

  Kishi, Takuya ^a  

^a KYUSHU UNIVERSITY   (Japan)

Author keywords

Brain; Nitric oxide; Oxidative stress; Sympathetic nerve activity

Indexed keywords

4 AMINOBUTYRIC ACID; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 1 RECEPTOR ANTAGONIST; ENDOTHELIAL NITRIC OXIDE SYNTHASE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ADRENERGIC SYSTEM; APOPTOSIS; ASTROCYTE; BRAIN STEM; HYPERTENSION; JAPANESE; MEDULLA OBLONGATA; NONHUMAN; OXIDATIVE STRESS; PROTEIN EXPRESSION; REGULATORY MECHANISM; REVIEW; ROSTRAL VENTROLATERAL MEDULLA; SIGNAL TRANSDUCTION; SOCIETY;

ANIMALS; AWARDS AND PRIZES; DISEASE MODELS, ANIMAL; HUMANS; HYPERTENSION; JAPAN; MEDULLA OBLONGATA; NITRIC OXIDE; OXIDATIVE STRESS; RATS; SOCIETIES, MEDICAL; SYMPATHETIC NERVOUS SYSTEM;

EID: 84885113944     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2013.73     Document Type: Review

References (125)

1. Grassi G. Assessment of sympathetic cardiovascular drive in human hypertension: achievements and perspectives. Hypertension 2009; 54: 690-697.
2. Grassi G. Sympathetic neural activity in human hypertension and related diseases. Am J Hypertens 2010; 23: 1052-1060.
3. Grassi G, Seravalle G, Quarti-Trevano F. The 'neurogenic hypothesis' in hypertension: current evidence. Exp Physiol 2010; 95: 581-586.
4. Esler M. The 2009 Carl Ludwig lecture: pathophysiology of the human sympathetic nervous system in cardiovascular diseases: the transition from mechanisms to medical management. J Appl Physiol 2010; 108: 227-237.
5. Mauo K, Lambert GW, Esler MD, Rakugi H, Ogihara T, Schlaich MP. The role of sympathetic nervous system activity in renal injury and end-stage renal disease. Hypertens Res 2010; 33: 521-528.
6. Dampney RAL. Functional organization of central pathways regulating the cardiovascular system. Physiol Rev 1994; 74: 323-364.
7. Guyenet PG. The sympathetic control of blood pressure. Nat Rev Neurosci 2006; 7: 335-346.
8. Pilowsky PM, Goodchild AK. Baroreceptor reflex pathways and neurotransmitters: 10 years on. J Hypertens 2002; 20: 1675-1688.
9. Sved AF, Ito S, Sved JC. Brainstem mechanisms of hypertension: role of the rostral ventrolateral medulla. Curr Hypertens Rep 2003; 5: 262-268.
10. Dampney RAL, Polson JW, Potts PD, Hirooka Y, Horiuchi J. Functional organization of brain pathways subserving the baroreceptor reflex: studies in conscious animals using immediate early gene expression. Cell Mol Neurobiol 2003; 23: 597-616.
11. Campos RR, Bergamschi CT. Neurotransmission alterations in central cardiovascular control in experimental hypertension. Curr Hypertens Rev 2006; 2: 193-198.
12. Carlson SH, Wyss JM. Neurohormonal regulation of the sympathetic nervous system: new insights into central mechanisms of action. Curr Hypertens Rep 2008; 10: 233-240.
13. Dampney RAL, Horiuchi J, Killinger S, Sheriff MJ, Tan PSP, McDowall LM. Long-term regulation of arterial blood pressure by hypothalamic nuclei: some critical questions. Clin Exp Pharmacol Physiol 2005; 32: 419-425.
14. Coote JH. Landmarks in understanding the central nervous control of the cardiovascular system. Exp Physiol 2007; 92: 3-18.
15. Krukoff TL. Central action of nitric oxide in regulation of autonomic functions. Brain Res Rev 1999; 30: 52-65.
16. Patel K, Li YF, Hirooka Y. Role of nitric oxide in central sympathetic outflow. Exp Biol Med 2001; 226: 814-824.
17. Zanzinger J. Role of nitric oxide in the neural control of cardiovascular function. Cardiovasc Res 1999; 43: 639-649.
18. Tai MH, Wang LL, Wu KLH, Chan JYH. Increased superoxide anion in rostral ventrolateral medulla contributes to hypertension in spontaneously hypertensive rats via interactions with nitric oxide. Free Rad Biol Med 2005; 38: 450-462.
19. Peterson JR, Sharma RV, Davisson RL. Reactive oxygen species in the neuropathogenesis of hypertension. Curr Hypertens Rep 2006; 8: 232-241.
20. Hirooka Y. Role of reactive oxygen species in brainstem in neural mechanisms of hypertension. Auton Neurosci 2008; 142: 20-24.
21. Campos RR. Oxidative stress in the brain and arterial hypertension. Hypertens Res 2009; 32: 1047-1048.
22. Hirooka Y, Sagara Y, Kishi T, Sunagawa K. Oxidative stress and central cardiovascular regulation: pathogenesis of hypertension and therapeutic aspects. Circ J 2010; 274: 827-835.
23. Hirooka Y. Oxidative stress in the cardiovascular center has a pivotal role in the sympathetic activation in hypertension. Hypertens Res 2011; 34: 407-412.
24. Hirooka Y, Kishi T, Sakai K, Takeshita A, Sunagawa K. Imbalance of central nitric oxide and reactive oxygen species in the regulation of sympathetic activity and neural mechanisms of hypertension. Am J Physiol 2011; 300: R818-R826.
25. Garthwaite J. Concepts of neural nitric oxide-mediated transmission. Eur J Neurosci 2008; 27: 2783-2802.
26. Talman WT, Dragon DN. Transmission of arterial baroreflex signals depends on neuronal nitric oxide synthase. Hypertension 2004; 43: 820-824.
27. Talman WT. NO and central cardiovascular control: a simple molecule with a complex story. Hypertension 2006; 48: 552-554.
28. TFC Batten, Atkinson L, Deuchars J. Nitric oxide systems in the medulla oblongata and their involvement in autonomic control. Functional neuroanatomy of the nitric oxide system, in Handbook of Chemical Neuroanatomy (eds Steinbusch HWM, De Vente J and Vincent SR) (Elsevier, Amsterdam, The Netherlands, 2000) pp 177-213.
29. Hirooka Y, Kishi T, Sakai K, Shimokawa H, Takeshita A. Effects of overproduction of nitric oxide in the brain stem on the cardiovascular response in conscious rats. J Cardiovasc Pharmacol 2003; 41 (Suppl 1), S119-S126.
30. Hirooka Y, Shigematsu H, Kishi T, Kimura Y, Ueta Y, Takeshita A. Reduced nitric oxide synthase in the brainstem contributes to enhanced sympathetic drive in rats with heart failure. J Cardiovasc Pharmacol 2003; 42 (Suppl 1), S111-S115.
31. Sakai K, Hirooka Y, Matsuo I, Eshima K, Shigematsu H, Shimokawa H, Takeshita A. Overexpression of eNOS in NTS causes hypotension and bradycardia in vivo. Hypertension 2000; 36: 1023-1028.
32. Hirooka Y, Polson JW, Dampney RAL. Pressor and sympathoexcitatory effects of nitric oxide in the rostral ventrolateral medulla. J Hypertens 1996; 14: 1317-1324.
33. Zanzinger J, Seller H. Species differences in the distribution of nitric oxide synthase in brain stem regions that regulate sympathetic activity. Brain Res 1997; 764: 265-268.
34. Chen SY, Mao SP, Chai CY. Role of nitric oxide on pressor mechanisms within the dorsomedial and rostral ventrolateral medulla in anesthetized cats. Clin Exp Pharmacol Physiol 2001; 28: 155-163.
35. Morimoto S, Sasaki S, Miki S, Kawa T, Nakamura K, Itoh H, Nakata T, Takeda K, Nakagawa M, Fushiki S. Nitric oxide is an excitatory modulator in the rostral ventrolateral medulla in rats. Am J Hypertens 2000; 13: 1125-1134.
36. Tseng CJ, Liu HY, Lin HC, Ger LP, Tung CS, Yen MH. Cardiovascular effects of nitric oxide in the brain stem nuclei of rats. Hypertension 1996; 27: 36-42.
37. Huang CC, Chan SH, Hsu KS. cGMP/protein kinase G-dependent potentiation of glutamatergic transmission induced by nitric oxide in immature rat rostral ventrolateral medulla neurons in vitro. Mol Pharmacol 2003; 64: 521-532.
38. Kishi T, Hirooka Y, Sakai K, Shigematsu H, Shimokawa H, Takeshita A. Overexpression of eNOS in the RVLM causes hypotension and bradycardia via GABA release. Hypertension 2001; 38: 896-901.
39. Kishi T, Hirooka Y, Ito K, Sakai K, Shimokawa H, Takeshita A. Cardiovascular effects of overexpression of endothelial nitric oxide synthase in the rostral ventrolateral medulla in stroke-prone spontaneously hypertensive rats. Hypertension 2002; 39: 264-268.
40. Kishi T, HIrooka Y, Kimura Y, Sakai K, Ito K, Shimokawa H, Takeshita A. Overexpression of eNOS in RVLM improves impaired baroreflex control of heart rate in SHRSP. Hypertension 2003; 41: 255-260.
41. Smith JK, Barron KW. GABAergic responses in ventrolateral medulla in spontaneously hypertensive rats. Am J Physiol 1990; 258: R450-R456.
42. Chang AY, Chan JY, Chan SH. Differential distribution of nitric oxide synthase isoforms in the rostral ventrolateral medulla of the rat. J Biomed Sci 2003; 10: 285-291.
43. Guo ZL, Tjen-A-Looi SC, Fu LW, Longhurst JC. Nitric oxide in rostral ventrolateral medulla regulates cardiac-sympathetic reflexes: role of synthase isoforms. Am J Physiol 2009; 297: H1478-H1486.
44. Martins-Pinge MC, Garcia MR, Zoccal DB, Crestani CC, Pinge-Filho P. Differential influences of iNOS and nNOS inhibitors on rostral ventrolateral medullary mediated cardiovascular control in conscious rats. Auton Neursci 2007; 131: 65-69.
45. Chan SH, Wang LL, Chan JY. Differential cardiovascular responses to blockade of nNOS or iNOS in rostral ventrolateral medulla of the rats. Br J Pharmacol 2001; 133: 606-614.
46. Ibrahim BM, Abdel-Rahman AA. Enhancement of rostral ventrolateral medulla neuronal nitric-oxide synthase-nitric-oxide signaling mediates the central cannabinoid receptor 1-evoked pressor response in conscious rats. J Pharmacol Exp Ther 2012; 341: 579-586.
47. Chan SH, Wang LL, Chan JY. Differential engagement of glutamate and GABA receptors in cardiovascular actions of endogenous nNOS or iNOS at rostral ventrolateral medulla of rats. Br J Pharmacol 2003; 138: 584-593.
48. Wang Y, Patel KP, Cornish KG, Channon KM, Zucker IH. nNOS gene transfer to RVLM improves baroreflex function in rats with chronic heart failure. Am J Physiol 2003; 285: H1660-H1667.
49. Kimura Y, Hirooka Y, Sagara Y, Ito K, Kishi T, Shimokawa H, Takeshita A, Sunagawa K. Overexpression of inducible nitric oxide synthase in rostral ventrolateral medulla causes hypertension and sympathoexcitation via an increase in oxidative stress. Circ Res 2005; 96: 252-260.
50. Kimura Y, Hirooka Y, Kishi T, Ito K, Sagara Y, Sunagawa K. Role of inducible nitric oxide synthase in rostral ventrolateral medulla in blood pressure regulation in spontaneously hypertensive rats. Clin Exp Hypertens 2009; 31: 281-286.
51. Chan JY, Wang LL, Wu KL, Chan SH. Reduced functional expression and molecular synthesis of inducible nitric oxide synthase in rostral ventrolateral medulla of spontaneously hypertensive rats. Circulation 2001; 104: 1676-1681.
52. Guo ZL, Longhurst J. Responses of neurons containing VGLUT3/nNOS-cGMP in the rVLM to cardiac stimulation. Neuroreport 2006; 17: 255-259.
53. Kishi T, Hirooka Y, Kimura Y, Ito K, Shimokawa H, Takeshita A. Increased reactive oxygen species in rostral ventrolateral medulla contributes to neural mechanisms of hypertension in stroke-prone spontaneously hypertensive rats. Circulation 2004; 109: 2357-2362.
54. Kishi T, Hirooka Y, Shimokawa H, Takeshita A, Sunagawa K. Atorvastatin reduced oxidative stress in the rostral ventrolateral medulla of stroke-prone spontaneously hypertensive rats. Clin Exp Hypertens 2008; 30: 3-11.
55. Kishi T, Hirooka Y, Konno S, Sunagawa K. Sympathoinhibition induced by centrally administered atorvastatin is associated with alteration of NAD(P)H oxidase and Mn superoxide dismutase activity in rostral ventrolateral medulla of stroke-prone spontaneously hypertensive rats. J Cardiovasc Pharmacol 2010b; 55: 184-190.
56. Kishi T, Sunagawa K. Experimental 'jet lag' causes sympathoexcitation via oxidative stress through AT1 receptor in the brainstem. Conf Proc IEEE Eng Med Biol Soc 2011; 2011: 1969-1972.
57. Kishi T, Hirooka Y, Ogawa K, Konno S, Sunagawa K. Calorie restriction inhibits sympathetic nerve activity via anti-oxidant effect in the rostral ventrolateral medulla of obesity-induced hypertensive rats. Clin Exp Hypertens 2011; 33: 240-245.
58. Kishi T, Hirooka Y, Sunagawa K. Sympathoinhibition caused by orally administered telmisartan through inhibition of AT(1) receptor in the rostral ventrolateral medulla. Hypertens Res 2012; 35: 940-946.
59. Kishi T, Hirooka Y, Katsuki M, Ogawa K, Shinohara K, Isegawa K, Sunagawa K. Exercise training causes sympathoinhibition through antioxidant effect in the rostral ventrolateral medulla of hypertensive rats. Clin Exp Hypertens 2012; 34: 278-283.
60. Kishi T, Sunagawa K. Combination therapy of atorvastatin and amlodipine inhibits sympathetic nervous system activation and improves cognitive function in hypertensive rats. Circ J 2012; 76: 1934-1941.
61. Konno S, Hirooka Y, Araki S, Koga Y, Kishi T, Sunagawa K. Azelnidipine decreases sympathetic nerve activity via antioxidant effect in the rostral ventrolateral medulla of stroke-prone spontaneously hypertensive rats. J Cardiovasc Pharmacol 2008; 52: 555-560.
62. Koga Y, Hirooka Y, Araki S, Nozoe M, Kishi T, Sunagawa K. High salt intake enhances blood pressure increase during development of hypertension via oxidative stress in rostral ventrolateral medulla of spontaneously hypertensive rats. Hypertens Res 2008; 31: 2075-2083.
63. Nishihara M, Hirooka Y, Matsukawa R, Kishi T, Sunagawa K. Oxidative stress in the rostral ventrolateral medulla modulates excitatory and inhibitory inputs in spontaneously hypertensive rats. J Hypertens 2012; 30: 97-106.
64. Konno S, Hirooka Y, Kishi T, Sunagawa K. Sympatho-inhibitory effect of telmisartan through the reduction of oxidative stress in rostral ventrolateral medulla of obesityinduced hypertensive rat. J Hypertens 2012; 30: 1992-1999.
65. Fujita M, Ando K, Nagae A, Fujita T. Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in salt-sensitive hypertension. Hypertension 2007; 50: 360-367.
66. Nagae A, Fujita M, Kawarazaki H, Matsui H, Ando K, Fujita T. Sympathoexcitation by oxidative stress in the brain mediates arterial pressure elevation in obesity-induced hypertension. Circulation 2009; 119: 978-986.
67. Oliveira-Sales EB, Dugaich AP, Carillo BA, Abreu NP, Boim MA, Martins PJ, D'Ameida V, Dolnkoff MS, Bergamaschi CT, Campos RR. Oxidative stress contributes to renovascular hypertension. Am J Hypertens 2008; 21: 98-104.
68. Oliveira-Sales EB, Nishi EE, Carillo BA, Dolnikoff MS, Bergamaschi CT, Campos RR. Oxidative stress in the sympathetic premotor neurons contributes to sympathetic activation in renovascular hypertension. Am J Hypertens 2009; 22: 484-492.
69. Oliveira-Sales EB, Colombari DSA, Davisson RL, Kasparov S, Hirata AE, Campos RR, Paton JFR. Kidney-induced hypertension depends on superoxide signaling in the rostral ventrolateral medulla. Hypertension 2010; 56: 290-296.
70. Nozoe M, Hirooka Y, Koga Y, Araki S, Konno S, Kishi T, Ide T, Sunagawa K. Mitochondria-derived reactive oxygen species mediate sympathoexcitation induced by angiotensin II in the rostral ventrolateral medulla. J Hypertens 2008; 26: 2176-2184.
71. Kishi T, Hirooka Y, Konno S, Ogawa K, Sunagawa K. Angiotensin II type 1 receptor activated caspase-3 through ras/mitogen-activated protein kinase/extracellular signal regulated kinase in the rostral ventrolateral medulla is involved in sympathoexcitation in stroke-prone spontaneously hypertensive rats. Hypertension 2010; 55: 291-297.
72. Chan SH, Hsu KS, Huang CC, Wang LL, Qu CC, Chan JY. NADPH oxidase-derived superoxide anion mediates angiotensin II-induced pressor effect via activation of p38 mitogen-activated protein kinase in the rostral ventrolateral medulla. Circ Res 2005; 97: 772-780.
73. Hu L, Zhu DN, Yu Z, Wang JQ, Sun ZJ, Yao T. Expression of angiotensin type 1 (AT1) receptor in the rostral ventrolateral medulla in rats. J Appl Physiol 2002; 92: 2153-2161.
74. Reja V, Goodchild AK, Phillips JK, Pilowsky PM. Upregulation of angiotensin AT1 receptor and intracellular kinase gene expression in hypertensive rats. Clin Exp Pharmacol Physiol 2006; 33: 690-695.
75. Leenen FHH. Brain mechanisms contributing to sympathetic hyperactivity and heart failure. Circ Res 2007; 101: 221-223.
76. Huang BS, Leenen FHH. The brain renin-angiotensin-aldosterone system: a major mechanism for sympathetic hyperactivity and left ventricular remodeling and dysfunction after myocardial infarction. Curr Heart Fail Rep 2009; 6: 81-88.
77. Zucker IH, Schultz HD, Patel KP, Wang W, Gao L. Regulation of central angiotensin type 1 receptors and sympathetic outflow in heart failure. Am J Physiol 2009; 297: H1557-H1566.
78. Dupont AG, Brouwers S. Brain angiotensin peptides regulate sympathetic tone and blood pressure. J Hypertens 2010; 28: 1599-1610.
79. Nozoe M, Hirooka Y, Koga Y, Sagara Y, Kishi T, Engelhardt JF, Sunagawa K. Inhibition of Rac1-derived reactive oxygen species in nucleus tractus solitarius decreases blood pressure and heart arte in stroke-prone spontaneously hypertensive rats. Hypertension 2007; 50: 62-68.
80. Zimmerman MC, Zucker IH. Mitochondrial dysfunction and mitochondria-produced reactive oxygen species: new aspects for neurogenic hypertension? Hypertension 2009; 53: 112-114.
81. Hirooka Y, Potts PD, Dampney RAL. Role of angiotensin II receptor subtypes in mediating the sympathoexcitatory effects of exogenous and endogenous angiotensin peptides in the rostral ventrolateral medulla. Brain Res 1997; 772: 107-114.
82. Dampney RAL, Tan PSP, Sheriff MJ, Fontes MAP, Horiuchi J. Cardiovascular effects of angiotensin II in the rostral ventrolateral medulla: the push-pull hypothesis. Curr Hypertens Rep 2007; 9: 222-227.
83. Shinohara K, Hirooka Y, Kishi T, Sunagawa K. Reduction of nitric oxide-mediated gamino butyric acid release in rostral ventrolateral medulla is involved in superoxideinduced sympathoexcitation of hypertensive rats. Circ J 2012; 76: 2814-2821.
84. Zielonka J, Zielonka M, Sikora A, Adamus J, Joseph J, Hardy M, Ouari O, Dranka BP, Kalyanaraman B. Global profiling of reactive oxygen and nitrogen species in biological systems: high-throughput real-time analysis. J Biol Chem 2012; 287: 2984-2995.
85. Zanzinger J. Mechanisms of action of nitric oxide in the brain stem: role of oxidative stress. Auton Neurosci 2002; 98: 24-27.
86. Sun J, Druhan LJ, Zweler JL. Reactive oxygen and nitrogen species regulate inducible nitric oxide synthase function shifting the balance of nitric oxide and superoxide production. Arch Biochem Biophys 2010; 494: 130-137.
87. Kung LC, Chan SH, Wu KL, Ou CC, Tai MH, Chan JY. Mitochondrial respiratory enzyme complexes in rostral ventrolateral medulla as cellular targets of nitric oxide and superoxide interaction in the antagonism of antihypertensive action of eNOS transgene. Mol Pharmacol 2008; 74: 1319-1332.
88. Rhee SG. Cell signaling, H2O2, a necessary evil for cell signaling. Science 2006; 312: 1882-1883.
89. Yu Y, Zhang ZH, Wei SG, Serrats J, Weiss RM, Felder RB. Brain perivascular macrophages and the sympathetic response to inflammation in rats after myocardial infarction. Hypertension 2010; 55: 652-659.
90. Hirooka Y. Brain perivascular macrophages and central sympathetic activation after myocardial infarction: heart and brain interaction. Hypertension 2010; 55: 610-611.
91. Cardinale JP, Sriramula S, Mariappan N, Agarwal D, Francis J. Angiotensin II-induced hypertension is modulated by nuclear factor-kB in the paraventricular nucleus. Hypertension 2011; 59: 113-121.
92. Shi P, Diez-Freire C, Jun JY, Qi Y, Katovich MJ, Li Q, Sriramula S, Francis J, Summers C, Raizada MK. Brain microglial cytokines in neurogenic hypertension. Hypertension 2010; 56: 297-303.
93. Kishi T, Hirooka Y, Sunagawa K. Autoimplantation of astrocytes into cardiovascular center of brainstem causes sympathoinhibition and decreases the mortality rate in hypertensive rats. Circulation 2010; 122: A13856.
94. Kishi T, Hirooka Y, Sunagawa K. Autoimplantation of astrocytes into the cardiovascular center of brainstem causes sympathoinhibition and decreases the mortality rate in myocardial infarction-induced heart failure. Circulation 2011; 124: A11489.
95. Kumagai H, Oshima N, Matsuura T, Iigaya K, Imai M, Onimaru H, Sakata K, Osaka M, Onami T, Takimoto C, Kamayachi T, Itoh H, Saruta T. Importance of rostral ventrolateral medulla neurons in determining efferent sympathetic nerve activity and blood pressure. Hypertens Res 2012; 35: 132-141.
96. Matsuura T, Kumagai H, Kawai A, Onimaru H, Imai M, Oshima N, Sakata K, Saruta T. Rostral ventrolateral medulla neurons of neonatal Wister-Kyoto and spontaneously hypertensive rats. Hypertension 2002; 40: 560-565.
97. Oshima N, Kumagai H, Onimaru H, Kawai A, Pilowski PM, Iigaya K, Takimoto C, Hayashi K, Saruta T, Itoh H. Monosynaptic excitatory connection from the rostral ventrolateral medulla to sympathetic pregangionic neurons revealed by simultaneous recording. Hypertens Res 2008; 31: 1445-1454.
98. Wu KL, Chan SH, Chan JY. Neuroinflammation and oxidative stress in rostral ventrolateral medulla contribute to neurogenic hypertension induced by systemic inflammation. J Neuroinflammation 2012; 9: 212.
99. Gao L, Li Y, Schultz HD, Wang WZ, Finch M, Smith LM, Zucker IH. Downregulated Kv4.3 expression in the RVLM as a potential mechanism for sympathoexcitation in rats with chronic heart failure. Am J Physiol 2010; 298: H945-H955.
100. Allen AM, MacGregor DP, McKinley MJ, Mendelsohn FAO. Angiotensin II receptors in the human brain. Regul Pept 1999; 79: 1-7.
101. McKinley MJ, Albiston AL, Allen AM, Mathai ML, May CN, McAllen RM, Oldfield BJ, Mendelsohn FAO, Chai SY. The brain renin-angiotensin system: location and physiological roles. Int J Biochem Cell Biol 2003; 35: 901-918.
102. Wang JM, Tan J, Leenen FHH. Central nervous system blockade by peripheral administration of AT1 receptor blockers. J Cardiovasc Pharmacol 2003; 41: 593-599.
103. Tsuchihashi T, Kagiyama S, Matsumura K, Abe I, Fujishima M. Effects of chronic oral treatment with imidapril and TCV-116 on the responsiveness to angiotensin II in ventrolateral medulla of SHR. J Hypertens 1999; 17: 917-922.
104. Nishimura Y, Ito T, Hoe KL, Saavedra JM. Chronic peripheral administration of the angiotensin II AT1 receptor antagonist candesartan blocks brain AT1 receptors. Brain Res 2000; 871: 29-38.
105. Gohlke P, Weiss S, Jansen A, Wienen W, Stangier J, Rascher W, Culman J, Unger T. AT1 receptor antagonist telmisartan administered peripherally inhibits central responses to angiotensin II in conscious rats. J Pharmacol Exp Ther 2001; 298: 62-70.
106. Leenen FHH, Yuan B. Prevention of hypertension by irbesartan in Dahl S rats relates to central angiotensin II type 1 receptor blockade. Hypertension 2001; 37: 981-984.
107. Lin Y, Matsumura K, Kagiyama S, Fukuhara M, Fujii K, Iida M. Chronic administration of olmesartan attenuates the exaggerated pressor response to glutamate in the rostral ventrolateral medulla of SHR. Brain Res 2005; 1058: 161-166.
108. Araki S, Hirooka Y, Kishi T, Yasukawa K, Utsumi H, Sunagawa K. Olmesartan reduces stress in the brain of stroke-prone spontaneously hypertensive rats assessed by an in vivo ESR method. Hypertens Res 2009; 32: 1091-1096.
109. Golomb BA, Dimsdale JE, White HL, Ritchie JB, Criqui MH. Reduction in blood pressure with statins: results from the USCD Statin Study, a randomized trial. Arch Intern Med 2008; 168: 721-727.
110. Sinski M, Lewandowsk J, Ciarka A, Bidiuk J, Abramczyk P, Dobosiewicz A, Gaciong Z. Atorvastatin reduced sympathetic activity and increases baroreceptor reflex sensitivity in patients with hypercholesterolemia and systemic arterial hypertension. Kardiol Pol 2009; 67: 613-620.
111. Kishi T, Hirooka Y. Sympathoinhibitory effects of atorvastatin in hypertension. Circ J 2010; 74: 2552-2553.
112. Siddiqi L, Joles JA, Oey PL, Blankestijn PJ. Atorvastatin reduced sympathetic activity in patients with chronic kidney disease. J Hypertens 2011; 29: 2176-2180.
113. Wassmann S, Laufs U, Muller K, Konkol C, Ahlbory K, Baumer AT, Linz W, Bohm M, Nickenig G. Cellular antioxidant effects of atorvastatin in vitro and in vivo. Arterioscler Thromb Vasc Biol 2002; 22: 300-305.
114. Kishi T, Hirooka Y, Mukai Y, Shimokawa H, Takeshita A. Atorvastatin causes depressor and sympathoinhibitory effects with upregulation of nitric oxide synthase in strokeprone spontaneously hypertensive rats. J Hypertens 2003; 21: 379-386.
115. Hirooka Y, Kimura Y, Nozoe M, Sagara Y, Ito K, Sunagawa K. Amlodipine-induced reduction of oxidative stress in the brain is associated with sympatho-inhibitory effects in stroke-prone spontaneously hypertensive rats. Hypertens Res 2006; 29: 49-56.
116. Shinohara K, Hirooka Y, Ogawa K, Kishi T, Yasukawa K, Utsumi H, Sunagawa K. Combination therapy of olmesartan and azelnidipine inhibits sympathetic activity associated with reducing oxidative stress in the brain of hypertensive rats. Clin Exp Hypertens 2012; 34: 456-464.
117. Iwanami J, Mogi M, Iwai M, Horiuchi M. Inhibition of the renin-angiotensin system and target organ protection. Hypertens Res 2009; 32: 229-237.
118. Mogi M, Horiuchi M. Effects of angiotensin II receptor blockers on dementia. Hypertens Res 2009; 32: 738-740.
119. Krum H, Schlaich MP, Whitbourn R, Sobotka P, Sadowski J, Bartus K, Kapelak B, Walton A, Sievert H, Thambar S, Abraham WT, Esler M. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proofof principle cohort study. Lancet 2009; 373: 1275-1281.
120. DiBona GF, Esler M. Translational medicine: the antihypertensive effect of renal denervation. Am J Physiol 2010; 298: R245-R253.
121. Simplicity HTN-2 Investigators. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Simplicity HTN-2 Trail): a randomized controlled trial. Lancet 2010; 376: 1903-1909.
122. Calaresu FR, Ciriello J. Renal afferent nerves affect discharge rate of medullary and hypothalamic single units in cat. J Auton Nerv Syst 1981; 3: 311-320.
123. Stella A, Golin R, Genovesi S, Zanchetti A. Renal reflexes in the regulation of blood pressure and sodium excretion. Can J Physiol Pharmacol 1987; 65: 1536-1539.
124. Ye S, Zhong H, Campese VM. Oxidative stress mediates the sympathetic nerve activity in the phenol renal injury model of hypertension. Hypertension 2006; 48: 309-315.
125. Campese VM, Shaohua Y, Huiquin Z. Oxidative stress mediates angiotensin II-dependent stimulation of sympathetic nerve activity. Hypertension 2005; 46: 533-539.